drugset / Trial / NCT03863249

Use of the xCELLigence System for Quantification of Bacterial Biofilm's Real Time Formation and Antibiotics Selection.

NCT03863249

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to develop an in vitro model of growth of oral biofilms, and validate xCELLigence system for the selection of an effective antibiotic treatment for each patient.

Timeline

Start
2019-02-08
Primary completion
2022-05-30
Completion
2022-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator AMOXICILIN Unknown
Comparator AZITROMYCIN Unknown
Comparator Metronidazole Small molecule